Verastem (VSTM) closed at $10.00 on October 26, 2026, down 0.4% from the previous close, on volume of 4,089,903 shares (30-day average 4,268,737).
Data as of October 26, 2026.
Verastem Oncology to Report Third Quarter 2026 Financial Results on November 5, 2026
Business Wire (Thu, 22-Oct 7:30 AM ET)
Market Chameleon (Wed, 14-Oct 6:29 AM ET)
Verastem Oncology Prices $250 Million Offering at $8.00 to Fund VS-7375 and Broader Pipeline Work
Market Chameleon (Wed, 14-Oct 3:05 AM ET)
Verastem Oncology Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants
Business Wire (Wed, 14-Oct 6:04 AM ET)
Verastem Oncology Announces Planned Chief Executive Officer Transition and Succession Plan
Business Wire (Wed, 14-Oct 6:01 AM ET)
Business Wire (Wed, 14-Oct 6:00 AM ET)
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire (Mon, 5-Oct 4:02 PM ET)
Verastem spotlights RAMP 201 data: triple wild-type LGSOC shows 18% ORR and 13-month mPFS
Market Chameleon (Fri, 2-Oct 5:27 AM ET)
Business Wire (Fri, 2-Oct 7:30 AM ET)
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Verastem trades on the NASDAQ stock market under the symbol VSTM.
As of October 26, 2026, VSTM stock price declined to $10.00 with 4,089,903 million shares trading.
VSTM has a beta of 1.98, meaning it tends to be more sensitive to market movements. VSTM has a correlation of 0.08 to the broad based SPY ETF.
VSTM has a market cap of $905.63 million. This is considered a Small Cap stock.
Last quarter Verastem reported $25 million in Revenue and -$.35 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.10.
In the last 3 years, VSTM traded as high as $14.22 and as low as $2.10.
The top ETF exchange traded funds that VSTM belongs to (by Net Assets): XBI, VTI, IWM, IWO, VXF.
VSTM has outperformed the market in the last year with a price return of +28.0% while the SPY ETF gained +15.1%. VSTM has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +61.8% and +19.3%, respectively, while the SPY returned +3.9% and -1.7%, respectively.
VSTM support price is $9.45 and resistance is $10.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VSTM shares will trade within this expected range on the day.
